2012 annual financial data
Nektar Therapeutics 2012 Operating margin
Direct answer
Operating margin was -173.91%.
Operating income was -141,201,000 USD and net income was -171,855,000 USD.
Operating cash flow was -129,756,000 USD.
Get free Nektar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 81,191,000 USD
- Operating income
- -141,201,000 USD
- Net income
- -171,855,000 USD
- Operating cash flow
- -129,756,000 USD